SGL-TX-MR—study protocol acute effects of SGLT2 inhibitor on kidney allograft oxygen tension, a randomized, double-blind, placebo controlled crossover trial
Lotte Borg Lange, Claus Bistrup · 2025
Read SGL-TX-MR—study protocol acute effects of SGLT2 inhibitor on kidney allograft oxygen tension, a randomized, double-blind, placebo controlled crossover trial by Lotte Borg Lange, Claus Bistrup (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12751442.txt.
Description
Drugs called SGLT2 inhibitors help protect kidneys, but no one had tested their quick effect in people who got a donor kidney and do not have diabetes. Lotte Borg Lange and Claus Bistrup set out a 2025 trial plan to fill that gap. Their study will take place at a transplant clinic at Odense University Hospital.
Eight adults with a stable donor kidney will each take a single dose of the drug and a placebo pill, in random order, with two weeks between the rounds. Scans that track oxygen in the kidney are the main measure, with blood flow, blood sugar, and blood pressure also checked. The team wants to learn if one dose raises oxygen levels in the kidney within hours. The results could guide later, larger trials in transplant care.
Catalog record
| CREATOR | Lotte Borg Lange, Claus Bistrup |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 107 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |